Showing results (101-110 of 193) with videos related to

Sort By:
Pageof 20
Journal of the European Academy of Dermatology and Venereology : JEADV|July 26, 2022
Genetic landscape of indolent and aggressive Kaposi sarcomasG G Malouf, X Lu, R Mouawad, et al.
Clinical and Experimental Dermatology|April 12, 2017
Extensive levamisole-induced vasculitisC Desvignes, C Becquart, D Launay, et al.
Archives of Dermatology|October 1, 1995
Essential mixed cryoglobulinemia. A comparative study of dermatologic manifestations in patients infected or noninfected with hepatitis C virusN Dupin, O Chosidow, F Lunel, et al.
The Journal of Antimicrobial Chemotherapy|May 31, 2018
Dynamics of drug resistance-associated mutations in HIV-1 DNA reverse transcriptase sequence during effective ARTA Nouchi, T Nguyen, M A Valantin, et al.
Journal of Clinical Microbiology|July 3, 1998
Line probe assay for detection of human immunodeficiency virus type 1 mutations conferring resistance to nucleoside inhibitors of reverse transcriptase: comparison with sequence analysisD Descamps, V Calvez, G Collin, et al.
Annales De Dermatologie Et De Venereologie|March 12, 2025
Value of tacrolimus 0.1% in the treatment of vitiligo in the era of targeted therapyA Duplaine, J Tannous, J Seneschal, et al.
Oncogene|December 3, 2013
YGLF motif in the Kaposi sarcoma herpes virus G-protein-coupled receptor adjusts NF-κB activation and paracrine actionsS Azzi, S S Smith, J Dwyer, et al.
Revue Neurologique|February 5, 1999
[Cognitive disorders in AIDS: clinical, virological and neuroradiological features]B Stankoff, S Suarez, O Rosemblum, et al.
Infectious Diseases Now|October 6, 2020
Low immune response rate of HIV-infected patients to a single injection of hepatitis A vaccineL Noël, R Tubiana, A Simon, et al.
British Journal of Cancer|March 30, 2006
Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapyV Martinez, E Caumes, L Gambotti, et al.
Pageof 20